Pirisudanol

	WikiDoc Resources for Pirisudanol
Articles
Most recent articles on Pirisudanol Most cited articles on Pirisudanol Review articles on Pirisudanol Articles on Pirisudanol in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Pirisudanol Images of Pirisudanol Photos of Pirisudanol Podcasts & MP3s on Pirisudanol Videos on Pirisudanol
Evidence Based Medicine
Cochrane Collaboration on Pirisudanol Bandolier on Pirisudanol TRIP on Pirisudanol
Clinical Trials
Ongoing Trials on Pirisudanol at Clinical Trials.gov Trial results on Pirisudanol Clinical Trials on Pirisudanol at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Pirisudanol NICE Guidance on Pirisudanol NHS PRODIGY Guidance FDA on Pirisudanol CDC on Pirisudanol
Books
Books on Pirisudanol
News
Pirisudanol in the news Be alerted to news on Pirisudanol News trends on Pirisudanol
Commentary
Blogs on Pirisudanol
Definitions
Definitions of Pirisudanol
Patient Resources / Community
Patient resources on Pirisudanol Discussion groups on Pirisudanol Patient Handouts on Pirisudanol Directions to Hospitals Treating Pirisudanol Risk calculators and risk factors for Pirisudanol
Healthcare Provider Resources
Symptoms of Pirisudanol Causes & Risk Factors for Pirisudanol Diagnostic studies for Pirisudanol Treatment of Pirisudanol
Continuing Medical Education (CME)
CME Programs on Pirisudanol
International
Pirisudanol en Espanol Pirisudanol en Francais
Business
Pirisudanol in the Marketplace Patents on Pirisudanol
Experimental / Informatics
List of terms related to Pirisudanol

Pirisudanol
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	N06BX08 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 2-(dimethylamino)ethyl[5-hydroxy-4-(hydroxymethyl)-6-methyl-3-pyridinyl]methylbutanedioate;
CAS Number	33605-94-6 ;
PubChem CID	65782;
ChemSpider	59202;
UNII	W618Z2SMVL;
KEGG	D07347 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C16H24N2O6
Molar mass	340.372 g/mol
3D model (JSmol)	Interactive image;
	SMILES CC1=NC=C(C(=C1O)CO)COC(=O)CCC(=O)OCCN(C)C;
	InChI InChI=1S/C16H24N2O6/c1-11-16(22)13(9-19)12(8-17-11)10-24-15(21)5-4-14(20)23-7-6-18(2)3/h8,19,22H,4-7,9-10H2,1-3H3; Key:KTOAWCPDBUCJED-UHFFFAOYSA-N;
(verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pirisudanol (Mentis, Menthen, Mentium, Nadex, Nadexen, Nadexon, Pridana, Stivane), also known as pyrisuccideanol, is the succinic acid ester of pyridoxine (a form of vitamin B₆) and of deanol (DMAE).^[1] It has been used in Europe in the treatment of mild cognitive impairment as well as fatigue and depression.^[1]^[2]^[3]^[4]^[5]

References

↑ ^1.0 ^1.1 [+http://www.dr-bob.org/cgi-bin/pb/mget.pl?post=/babble/20010708/msgs/69493.html#69493 "Psycho-Babble Medication Thread 69493"] Check |url= value (help).
↑ David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
↑ Bathien N, Willer JC, Hugelin A (1976). "[Effect of psychotropic drugs on physiological variations and psychometric scores during attention]". L'Encéphale (in French). 2 (1): 55–60. PMID 1261486.
↑ Murphy JE (1981). "An evaluation of pyrisuccideanol maleate (Nadex) in the treatment of mild to moderate depression in patients aged 55 years and over, presenting in general practice". The Journal of International Medical Research. 9 (5): 330–7. PMID 7297757.
↑ Zmorski T (September 1983). "[Experience with Nadex in an ambulatory psychiatric practice]". Therapeutische Umschau. Revue Thérapeutique (in German). 40 (9): 817–20. PMID 6138876.

Template:Nootropics Template:Antidepressants

[urlPsycho-Babble_Medication_Thread_69493-1] 1.0 ^1.1 [+http://www.dr-bob.org/cgi-bin/pb/mget.pl?post=/babble/20010708/msgs/69493.html#69493 "Psycho-Babble Medication Thread 69493"] Check |url= value (help).

[isbn0-412-46630-9-2] David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.

[pmid1261486-3] Bathien N, Willer JC, Hugelin A (1976). "[Effect of psychotropic drugs on physiological variations and psychometric scores during attention]". L'Encéphale (in French). 2 (1): 55–60. PMID 1261486.

[pmid7297757-4] Murphy JE (1981). "An evaluation of pyrisuccideanol maleate (Nadex) in the treatment of mild to moderate depression in patients aged 55 years and over, presenting in general practice". The Journal of International Medical Research. 9 (5): 330–7. PMID 7297757.

[pmid6138876-5] Zmorski T (September 1983). "[Experience with Nadex in an ambulatory psychiatric practice]". Therapeutische Umschau. Revue Thérapeutique (in German). 40 (9): 817–20. PMID 6138876.

[1]

[2]

[3]

[4]

[5]

Pirisudanol

Overview

See also

References

Navigation menu

Clinical data

AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	N06BX08 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name 2-(dimethylamino)ethyl[5-hydroxy-4-(hydroxymethyl)-6-methyl-3-pyridinyl]methylbutanedioate
CAS Number	33605-94-6^Y
PubChem CID	65782
ChemSpider	59202
UNII	W618Z2SMVL
KEGG	D07347^Y
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₁₆H₂₄N₂O₆
Molar mass	340.372 g/mol
3D model (JSmol)	Interactive image
SMILES CC1=NC=C(C(=C1O)CO)COC(=O)CCC(=O)OCCN(C)C
InChI InChI=1S/C16H24N2O6/c1-11-16(22)13(9-19)12(8-17-11)10-24-15(21)5-4-14(20)23-7-6-18(2)3/h8,19,22H,4-7,9-10H2,1-3H3 Key:KTOAWCPDBUCJED-UHFFFAOYSA-N
(verify)